Ralph Schiess
Chief Executive Officer at ONCONETIX, INC.
Net worth: 55 568 $ as of 31/05/2024
Ralph Schiess active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ONCONETIX, INC. | Chief Executive Officer | 12/01/2024 | - |
| Chief Tech/Sci/R&D Officer | 15/12/2023 | - | |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Chief Executive Officer | 01/01/2010 | - |
| Founder | 01/01/2010 | - | |
| Director/Board Member | 01/01/2010 | 01/01/2020 | |
| Chief Tech/Sci/R&D Officer | 01/01/2020 | 01/05/2023 |
Career history of Ralph Schiess
Training of Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Statistics
International
| Switzerland | 3 |
| Germany | 2 |
| United States | 2 |
Operational
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Ralph Schiess
- Experience
